Literature DB >> 27126683

Controversies in venous thromboembolism: the unique case of isolated distal deep vein thrombosis.

Angelo Porfidia1, Annamaria Carnicelli1, Nicola Bonadia1, Roberto Pola1, Raffaele Landolfi2.   

Abstract

Venous thromboembolism (VTE) represents the third leading cause of cardiovascular mortality, and it is the main cause of preventable mortality in hospitalized patients. Among VTE, there is the unique case of isolated distal deep vein thrombosis (IDDVT), which still lacks an agreement in terms of optimal therapeutic strategy. Although most IDDVTs are self-limiting and associated with a very low risk of embolic complications, still not all IDDVTs can be safely identified as stable. Lack of strong scientific evidence, fear of thromboembolic complications, and risk of bleeding upon initiation of anticoagulant treatment result in very heterogeneous therapeutic strategies among physicians. Here, we provide a comprehensive review of the literature, highlight the many controversial issues regarding IDDVTs, and call for a consensus of experts aimed to shed new light on the gray areas of IDDVT management and therapy.

Entities:  

Keywords:  Anticoagulant; Calf thrombosis; IDDVT; Isolated distal deep vein thrombosis

Mesh:

Substances:

Year:  2016        PMID: 27126683     DOI: 10.1007/s11739-016-1453-3

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  35 in total

Review 1.  Clinical relevance of distal deep vein thrombosis.

Authors:  Marc Righini; Henri Bounameaux
Journal:  Curr Opin Pulm Med       Date:  2008-09       Impact factor: 3.155

2.  Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis.

Authors:  J-P Galanaud; M-A Sevestre; C Genty; S R Kahn; G Pernod; C Rolland; A Diard; S Dupas; C Jurus; J-M Diamand; I Quere; J-L Bosson
Journal:  J Thromb Haemost       Date:  2014-04       Impact factor: 5.824

Review 3.  The controversy of managing calf vein thrombosis.

Authors:  Elna M Masuda; Robert L Kistner; Chayanin Musikasinthorn; Fernando Liquido; Olga Geling; Qimei He
Journal:  J Vasc Surg       Date:  2011-10-26       Impact factor: 4.268

4.  A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

Authors:  S Schulman; A S Rhedin; P Lindmarker; A Carlsson; G Lärfars; P Nicol; E Loogna; E Svensson; B Ljungberg; H Walter
Journal:  N Engl J Med       Date:  1995-06-22       Impact factor: 91.245

5.  Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study.

Authors:  Thomas Schwarz; Lutz Buschmann; Jan Beyer; Kai Halbritter; Aljosha Rastan; Sebastian Schellong
Journal:  J Vasc Surg       Date:  2010-07-13       Impact factor: 4.268

Review 6.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

7.  Deep venous thrombosis and the risk of pulmonary embolism. A systematic study.

Authors:  M Monreal; J Ruíz; A Olazabal; A Arias; J Roca
Journal:  Chest       Date:  1992-09       Impact factor: 9.410

Review 8.  How I treat isolated distal deep vein thrombosis (IDDVT).

Authors:  Gualtiero Palareti
Journal:  Blood       Date:  2014-01-28       Impact factor: 22.113

9.  Is it worth diagnosing and treating distal deep vein thrombosis? No.

Authors:  M Righini
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

10.  The anticoagulation of calf thrombosis (ACT) project: results from the randomized controlled external pilot trial.

Authors:  Daniel Horner; Kerstin Hogg; Richard Body; Michael J Nash; Trevor Baglin; Kevin Mackway-Jones
Journal:  Chest       Date:  2014-12       Impact factor: 9.410

View more
  6 in total

Review 1.  Landmark trials in thrombotic vascular disease: a critical appraisal of potential practice-changing trials in 2016-2017.

Authors:  Andrea Cervi; James Demetrios Douketis
Journal:  Intern Emerg Med       Date:  2018-07-27       Impact factor: 3.397

2.  Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry.

Authors:  Behnood Bikdeli; César Caraballo; Javier Trujillo-Santos; Jean Philippe Galanaud; Pierpaolo di Micco; Vladimir Rosa; Gemma Vidal Cusidó; Sebastian Schellong; Meritxell Mellado; María Del Valle Morales; Olga Gavín-Sebastián; Lucia Mazzolai; Harlan M Krumholz; Manuel Monreal
Journal:  JAMA Cardiol       Date:  2022-08-01       Impact factor: 30.154

3.  Outcomes of isolated distal thrombosis managed with serial compression ultrasonography.

Authors:  Alexandra C Brewster; Aubrey E Jones; Stacy A Johnson; John A Saunders; Daniel M Witt
Journal:  Thromb Res       Date:  2021-10-21       Impact factor: 10.407

4.  Proximal and isolated distal deep vein thrombosis and Wells score accuracy in hospitalized patients.

Authors:  Michelangelo Sartori; Filippo Gabrielli; Elisabetta Favaretto; Massimo Filippini; Ludovica Migliaccio; Benilde Cosmi
Journal:  Intern Emerg Med       Date:  2019-03-12       Impact factor: 3.397

5.  Incidence of Deep Vein Thrombosis and Venous Thromboembolism following TKA in Rheumatoid Arthritis versus Osteoarthritis: A Meta-Analysis.

Authors:  Do-Kyung Lee; Hyun-Jung Kim; Dae-Hee Lee
Journal:  PLoS One       Date:  2016-12-02       Impact factor: 3.240

6.  Differences in Clinical Presentation, Rate of Pulmonary Embolism, and Risk Factors Among Patients With Deep Vein Thrombosis in Unusual Sites.

Authors:  Angelo Porfidia; Enrica Porceddu; Daniela Feliciani; Marzia Giordano; Fabiana Agostini; Giulia Ciocci; Giulia Cammà; Igor Giarretta; Eleonora Gaetani; Paolo Tondi; Roberto Pola
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.